Dhampur Bio Organics Limited EBIT

Dhampur Bio Organics Limited (DBOL.BO) currently reports a EBIT of $1.1B as of June 2026. That compares with $500M in the prior-year period — up 126.5% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore Dhampur Bio Organics Limited's EBIT history and peer comparisons.

Dhampur Bio Organics Limited's EBIT increased from $500M to $1.1B — a 126.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dhampur Bio Organics Limited's EBIT of $1.1B is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Dhampur Bio Organics Limited reported $1.1B in EBIT as of June 2026. That compares with $500M in the prior-year period — up 126.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $1.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for Dhampur Bio Organics Limited, and consider following DBOL.BO for alerts when major investors trade the stock.